Search results for:

rifAMPin

rifAMPin
Brand names: Rifadin, Rifadin IV
Form Strength
CAPSULE, ORAL 300 mg
POWDER FOR INJECTION, INTRAVENOUS 600 mg
SOLUTION, ORAL 150 mg/15 mL


Medication comments:
Per policy, these drugs are subject to renal dosing adjustments by pharmacy. 
Generic + Route
(Brand)
• Indications
Usual Adult Dose
Comments
Renal Dosage Adjustments
rifAMPin IV/PO 300-600 mg daily No adjustment necessary
Per policy, these drugs may be converted from IV to PO in patients who meet criteria.  
rifampin may convert from IV to PO on a mg-to-mg basis.

Last updated: Oct. 16, 2024
  • Renal Adjustment Policy rifAMPin subject to adjustments by pharmacy.
  • IV to PO Conversion Policy Policy
  • Look-Alike/Sound-Alike rifAMPin confused with Rifamate, rifAXIMin



Pharmacy Contact Info:

Main Inpatient Pharmacy: ext 4599, 3503
Fax: 704-878-7283

Director of Pharmacy - Randi Raynor, PharmD: ext 4501
Clinical Coordinator - Laura Rollings, PharmD: ext 4597
Pharmacy Informaticist - Stephen Pringle, PharmD: ext 7645
Pharmacy Technician Supervisor - Amy Wingler, CPhT: ext 7385
Pharmacy Automation Coordinator (Omnicell) - Melissa Fulford, CPhT: ext 3556



This site is intended for the staff of Iredell Health System. While others may view accessible pages, Iredell Health System makes no warranty, express or implied, as to the use of this information outside of Iredell Health System. The content of this policy and procedure document serves as guidance to the delivery of quality patient care. Care providers are expected to exercise critical thinking and situational awareness skills, and in specific situations to take such action as is necessary for the delivery of quality patient care.